Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06052969 · ClinicalTrials.gov registry record · NA
Pulse Endovascular ReperFUSION for Acute Ischemic Stroke
A NA study of Acute Ischemic Stroke AIS and Cerebral Arterial Disease, sponsored by Euphrates Vascular.
- Recruiting
- Registry status
- NA
- Development phase
- 8
- Enrollment target
- 1
- Study location
NCT06052969 is a NA study of Acute Ischemic Stroke AIS and Cerebral Arterial Disease that is actively recruiting participants, run by Euphrates Vascular. The registered enrollment target is 8 participants. The trial reports 1 study location across 1 state.
The verdict
NCT06052969, a NA study of Acute Ischemic Stroke AIS and Cerebral Arterial Disease, is actively recruiting participants, sponsored by Euphrates Vascular.
- RECRUITING
- Registry status
- NA
- Development phase
- 8 participants
- Enrollment target
- 1
- Study location
Study Summary
Prospective, multi-center, single-arm early feasibility study enrolling a minimum of 15 subjects at up to a minimum of 3 active investigational sites in the United States. The subjects must be diagnosed with acute ischemic stroke (AIS), must be post-mechanical thrombectomy, will have had intravenous thrombolytics, and have a visible MCA, ACA or PCA occlusive clot on initial angiographic imaging. Each subject will receive the Pulse NanoMED procedure after attempted neurovascular therapy to achieve better reperfusion.
Conditions Studied
Interventions
- DEVICE Pulse NanoMED System
Study Locations (1)
South Carolina
- University of South Carolina - Prisma - Columbia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2023-10-01 |
| Est. Completion | 2026-03-15 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06052969
The ClinicalTrials.gov registry entry for NCT06052969 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 8 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Euphrates Vascular, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Acute Ischemic Stroke AIS appearing as the primary indexed condition, and to 1 intervention - of which Pulse NanoMED System is the first listed.
NCT06052969 reports 1 study location spanning 1 distinct geographic area - top geographies include South Carolina.
Frequently Asked Questions
What is clinical trial NCT06052969 about?
NCT06052969 is a clinical study titled "Pulse Endovascular ReperFUSION for Acute Ischemic Stroke". Prospective, multi-center, single-arm early feasibility study enrolling a minimum of 15 subjects at up to a minimum of 3 active investigational sites in the United States. The subjects must be diagnosed with acute ischemic stroke (AIS), must be post-mechanical thrombectomy, will have had intravenou...
What is the current status of trial NCT06052969?
This trial is currently recruiting. It is a NA study. The enrollment target is 8 participants. The study started on 2023-10-01. Estimated completion is 2026-03-15.
What conditions does trial NCT06052969 study?
This clinical trial studies the following conditions: Acute Ischemic Stroke AIS, Cerebral Arterial Disease.
What interventions are being tested in trial NCT06052969?
The interventions under investigation include: Pulse NanoMED System (DEVICE).
Who is sponsoring clinical trial NCT06052969?
This trial is sponsored by Euphrates Vascular, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06052969 being conducted?
This trial has 1 study location across South Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Acute Ischemic Stroke AIS
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Explore more on PlainTrial
Acute Ischemic Stroke AIS
All registered trials for this condition
Cerebral Arterial Disease
All registered trials for this condition
South Carolina
All trials with a study site in South Carolina
Recruiting now
Find trials open to new participants near you
Rankings
Top sponsors, conditions, and phases
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.